Joe Zhou Lab

The Zhou lab studies the pancreatic insulin-secreting beta-cells and the gut stem cells.

[Joe Zhou Lab @JoeZhouLab]

Please join us as we celebrate the life and legacy of Dr. Joe Q. Zhou...

[Joe Zhou Lab @JoeZhouLab]

NYC*T1D Network website launched. Check it out! https://t.co/kjlSK20Ixg

[Joe Zhou Lab @JoeZhouLab]

ASGCT (American Society of Gene & Cell Therapy) 2023 Annual Meeting in Los Angeles

[Steve Huang @XfSteveHuang]

Paper online! Read my latest #research on restoring homeostasis with gastric insulin-secreting (#GINS) #organoids. It's about a novel #Autologous #CellTherapy for #diabetes, published with @SpringerNature in @NatureCellBio. Read here: https://t.co/WzRqjVeqqJ

[Joe Zhou Lab @JoeZhouLab]

@XfSteveHuang
Xiaofeng presented the story of GINS organoids at the 4th IPITA/HSCI/JDRF Summit on Stem Cell Derived Beta Cells. Here is the abstract: https://t.co/AUhWpt13W4

[Joe Zhou Lab @JoeZhouLab]

We presented our works at Keystone Stem Cells and Organoids Joint Meeting https://t.co/hHPVKPfl4e

[Joe Zhou Lab @JoeZhouLab]

Congratulations to Steve on his paper in Nature Cell Biology!
An important step (milestone) toward generating personalized cell therapy to treat type 1 and type 2 diabetes.

[Steve Huang @XfSteveHuang]

Our manuscript was accepted by NCB! In this study, we developed a robust 3-step protocol to induce cultured human gastric stem cells (hGSCs) from multiple donors to differentiate into functional islet-like gastric insulin-secreting (GINS) organoids. (1/8)
https://t.co/PDQLP7HK8T

[Joe Zhou Lab @JoeZhouLab]

Dr. Xiaofeng Steve Huang @XfSteveHuang presented his work “Restoring Glucose Homeostasis with Stomach-derived Human Insulin-Secreting Organoids” in 2022 Annual Investigator Hybrid Meeting of Human Islet Research Network (HIRN).

[HIRN @HIRN_CC]

Thank you to all HIRN members that participated our latest meeting. It was great seeing so many in person & online for #HIRN2022

Our membership reflects a wide variety of research specialities, experiences, and techniques yet all are committed to #diabetes #T1D #T2D research.

[Joe Zhou Lab @JoeZhouLab]

Joe Zhou and Remi Creusot organized the 2nd Symposium of the NYC*T1D Network (Type 1 Diabetes in New York City) at the New York Stem Cell Foundation. We have over 20 laboratories and 3 foundations participating. #Type1Diabetes #NYC #StemCells

[Joe Zhou Lab @JoeZhouLab]

Congratulations to Steve @XfSteveHuang ! He won the second place of oral presentation in Postdoc Research Day 2022!

[WCMPostdocs @WCMPostdocs]

🗣📊 Dr. Xiaofeng (Steve) Huang @XfSteveHuang, Postdoctoral Associate in Medicine in the @JoeZhouLab at @WeillCornell, told us about his research on stomach-derived human organoids that can be used as a potential cell-based therapy for the treatment of diabetes.

[Joe Zhou Lab @JoeZhouLab]

Dr. Joe Zhou presented Dr. Wei Gu's work @weill35770177 "SATB2 controls colon vs small intestine stem cell identity" in Gordon Research Conference

[Joe Zhou Lab @JoeZhouLab]

Dr. Xiaofeng Huang @XfSteveHuang presented his work "Redirecting differentiation of human stomach stem cells to produce pancreatic islet-like organoids for diabetes treatment" in Gordon Research Conference

[AMSNY @AMSNewYork]

Our President and CEO, Jo Wiederhorn, urges Gov. Kathy Hochul to re-establish the critical #NYSTEM research program in this @CrainsNewYork op-ed: https://t.co/txan5J0yDO @GovKathyHochul

[Crain's New York @CrainsNewYork]

Op-ed: The governor should re-establish state's defunded stem cell science program. To be a hub for life sciences and benefit from economic development this sector provides, New York must invest in research, not cut it https://t.co/PQ0fkuY60w

[Joe Zhou Lab @JoeZhouLab]

Researchers Discover the Role the Gene SATB2 Plays in the Colon Lining https://t.co/LL6HPDn08I

[Cell Stem Cell @CellStemCell]

New Article online now CellStemCell: SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling https://t.co/I6ufVptORZ

[HIRN @HIRN_CC]

Xiaofeng Huang is a Postdoc: His current research goal is to develop a technology to derive large numbers of functional insulin-secreting cells from the abundant renewable sources of human gastric stem cells to treat Type 1 Diabetes.

#HIRN2021Scholarship